NDC 82958-501 – Encelto

Revakinagene Taroretcel-lwey 440000 [arb'U]/1 · Implant · Intravitreal

Human Prescription Drug

Product NDC82958-501

Product details

Brand name
Encelto
Generic name
Revakinagene taroretcel-lwey
Labeler
Neurotech Pharmaceuticals, Inc.
Dosage form
Implant
Route
Intravitreal
Marketing category
BLA · BLA125798
Marketed since
March 12, 2025
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Encelto →

Package NDC codes (1)

Package NDCDescriptionSince
82958-501-011 CAPSULE in 1 CONTAINER (82958-501-01) / 1 IMPLANT in 1 CAPSULEMar 12, 2025